ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Shire Biopharmaceuticals Holdings

Shire Biopharmaceuticals Holdings is a dissolved company incorporated on 27 June 2005 with the registered office located in London, Greater London. Shire Biopharmaceuticals Holdings was registered 20 years ago.
Status
Dissolved
Dissolved on 12 September 2023 (2 years ago)
Was 18 years old at the time of dissolution
Via voluntary strike-off
Company No
05492592
Private unlimited company
Age
20 years
Incorporated 27 June 2005
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Not Submitted
Awaiting first confirmation statement
Accounts
Not Submitted
Awaiting first accounts
Contact
Address
1 Kingdom Street
London
W2 6BD
United Kingdom
Same address for the past 8 years
Telephone
Unreported
Email
Available in Endole App
Website
People
Officers
2
Shareholders
1
Controllers (PSC)
1
Director • Accountant • British • Lives in UK • Born in Feb 1985
Director • Finance Director • American • Lives in England • Born in Mar 1981
Takeda Pharmaceutical Company Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Shire Pharmaceutical Contracts Limited
Peter Michael Grubin and Marc Stuart Page are mutual people.
Active
Shire Pharmaceuticals Limited
Peter Michael Grubin and Marc Stuart Page are mutual people.
Active
Takeda Cambridge Limited
Peter Michael Grubin and Marc Stuart Page are mutual people.
Active
Takeda Development Centre Europe Ltd
Peter Michael Grubin and Marc Stuart Page are mutual people.
Active
Takeda UK Limited
Peter Michael Grubin is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2012–2021)
Period Ended
31 Dec 2021
For period 31 Dec31 Dec 2021
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£1.25B
Decreased by £335.82M (-21%)
Total Liabilities
-£2.05M
Decreased by £424.99M (-100%)
Net Assets
£1.25B
Increased by £89.17M (+8%)
Debt Ratio (%)
0%
Decreased by 26.81% (-99%)
Latest Activity
Voluntarily Dissolution
2 Years Ago on 12 Sep 2023
Voluntary Gazette Notice
2 Years 2 Months Ago on 27 Jun 2023
Application To Strike Off
2 Years 3 Months Ago on 16 Jun 2023
Takeda Corporate Services Limited Resigned
2 Years 3 Months Ago on 31 May 2023
Full Accounts Submitted
2 Years 5 Months Ago on 13 Apr 2023
Mark Gibbons Resigned
2 Years 10 Months Ago on 8 Nov 2022
Mr Marc Stuart Page Appointed
2 Years 10 Months Ago on 8 Nov 2022
Confirmation Submitted
3 Years Ago on 1 Jul 2022
Kentaro Shirahata Resigned
3 Years Ago on 1 Mar 2022
Peter Michael Grubin Appointed
3 Years Ago on 1 Mar 2022
Get Credit Report
Discover Shire Biopharmaceuticals Holdings's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Final Gazette dissolved via voluntary strike-off
Submitted on 12 Sep 2023
First Gazette notice for voluntary strike-off
Submitted on 27 Jun 2023
Application to strike the company off the register
Submitted on 16 Jun 2023
Termination of appointment of Takeda Corporate Services Limited as a secretary on 31 May 2023
Submitted on 2 Jun 2023
Resolutions
Submitted on 25 May 2023
Full accounts made up to 31 December 2021
Submitted on 13 Apr 2023
Appointment of Mr Marc Stuart Page as a director on 8 November 2022
Submitted on 10 Nov 2022
Termination of appointment of Mark Gibbons as a director on 8 November 2022
Submitted on 10 Nov 2022
Resolutions
Submitted on 7 Nov 2022
Confirmation statement made on 1 July 2022 with no updates
Submitted on 1 Jul 2022
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year